Back
Extreme Networks 10K Form
Buy
54
EXTR
Extreme Networks
Last Price:
$13.99
Seasonality Move:
11.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | EXTR/Extreme Networks Quarterly |
2024-02-01 | 10Q | EXTR/Extreme Networks Quarterly |
2023-11-02 | 10Q | EXTR/Extreme Networks Quarterly |
2023-04-27 | 10Q | EXTR/Extreme Networks Quarterly |
2023-01-27 | 10Q | EXTR/Extreme Networks Quarterly |
2022-10-28 | 10Q | EXTR/Extreme Networks Quarterly |
Receive EXTR News And Ratings
See the #1 stock for the next 7 days that we like better than EXTR
EXTR Financial Statistics
Sales & Book Value
Annual Sales: | $1.1B |
---|---|
Cash Flow: | $24.2M |
Price / Cash Flow: | 29.41 |
Annual Sales: | $0.54 |
Price / Book: | 25.98 |
Profitability
EPS (TTM): | -0.41000 |
---|---|
Net Income (TTM): | $-53.9M |
Gross Margin: | $630.8M |
Return on Equity: | -109.54% |
Return on Assets: | -5.05% |
Extreme Networks Earnings Forecast
Key Extreme Networks Financial Ratios
-
The Gross Profit Margin over the past 27 years for EXTR is 56.47%.
-
The Selling, General & Administrative Expenses for EXTR have been equal to 39.90% of Gross Profit Margin.
-
The Research & Development expenses have been 18.97% of Revenue.
-
The Net Earning history of EXTR is -7.69% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 13 years.
Extreme Networks Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Communications Equipment |
Sector: | Information Technology |
Current Symbol: | EXTR |
CUSIP: | 30226D |
Website: | extremenetworks.com |
Debt
Debt-to-Equity Ratio: | 2.51 |
---|---|
Current Ratio: | 0.93 |
Quick Ratio: | 0.56 |
Price-to-Earnings
Trailing P/E Ratio: | 19.74 |
---|---|
Forward P/E Ratio: | 13.94 |
EXTR Technical Analysis vs Fundamental Analysis
Buy
54
Extreme Networks (EXTR)
is a Buy
Is Extreme Networks a Buy or a Sell?
-
Extreme Networks stock is rated a BuyThe current Extreme Networks [EXTR] share price is $13.99. The Score for EXTR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.